Dear Sir, The World Health Organization (WHO) Classification of Tumors series, published as the WHO Blue Books (Fig. 1) and the accompanying website, are essential resources for pathologists across the globe, providing the standards against which tumors are classified to aid cancer diagnosis, research, treatment and prognosis. Each book tackles the classifications of up to 300 tumor types, defining for each of these the etiology, pathogenesis, epidemiology, clinical features, macroscopic appearances, histology, cytology, molecular pathology, essential and desirable diagnostic features, staging, prognostic factors and predictive biomarkers. If each tumor were to require one formal review, this would mean finding or conducting up to 3,600 such reviews for each book which would not be practicable or time-efficient. The current approach therefore relies largely on subject experts drawing on published literature searches according to their individually perceived need to inform the content of these books. However, these decisions affect the classification, and hence the diagnosis and management of cancer patients worldwide. Consequently, to minimize the risk of including biased information, the evidence is weighed and decisions made by an editorial board. This editorial board is composed of standing members and content experts (mainly practicing pathologists) who meet, propose, revise and agree on definitions and core criteria for each tumor systematically for every new edition.Over-reliance on expert consensus at editorial board meetings for this purpose may lead to problems (Table 1). First, evidence needs to be reviewed to assess all relevant issues in a WHO Blue Book. But, even if all participating experts are required to perform literature reviews, their different expertise and inevitable time constraints produce variable results with potential for studies that are relevant to decisions to be missed. In the first book of the new 5th edition, up to 130 tumors or subjects were described as "unknown" and 200 labeled as clinically not relevant, this often being the only description of a whole section. 1 Sections such as etiology or pathogenesis are frequently summarized as "unknown," without providing more details, leaving unclear whether an exhaustive search of the literature has been performed. This does not necessarily indicate that systematic reviews should be routinely performed when such questions arise and indeed, it would not be possible for standing members and content experts to do so given the number that would be required. Often the statements requiring evidence are more related to background information than issues relevant to classification, and introducing systematic approaches to the literature searches would not improve the evidence base of the review results.